Osteoporosis
Conference Coverage
More dairy lowers risk of falls, fractures in frail elderly
Results from the first randomized trial to show a benefit of dairy food intake on risk of fractures leave it unclear whether it is better to get...
Conference Coverage
Mega vitamin D harms bone in women, not men, without osteoporosis
Conference Coverage
ASBMR 2020: Sequential osteoporosis meds, AI, bone cancer, and more
The virtual meeting will provide the latest information about basic research and clinical treatment of bone disease, from sequential osteoporosis...
From the Journals
CagA-positive H. pylori patients at higher risk of osteoporosis, fracture
Study adds additional weight to previous findings regarding H. Pylori infection and bone fragility, particularly among CagA-positive...
From the Journals
Atypical fractures with bisphosphonates highest in Asians, study confirms
The benefits of bisphosphonates in fracture reduction still far outweigh risks for atypical femur fractures, but the study shows a higher risk for...
From the Journals
SGLT2 inhibitors with metformin look safe for bone
A meta-analysis of clinical trials finds no significant increase in fracture rate in type 2 diabetes patients taking SLGT-2 inhibitors plus...
From the Journals
Fracture risk prediction: No benefit to repeat BMD testing in postmenopausal women
But experts advise against a broad recommendation to skip repeat testing in the general population.
From the Journals
Low vitamin D linked to increased COVID-19 risk
A large study evaluates associations between low serum vitamin D levels and risks for acquiring COVID-19 and hospitalization.
Latest News
Delaying denosumab dose boosts risk for vertebral fractures
Physicians say patients may skip regular injections of the osteoporosis drug amid the pandemic.
From the Journals
Bisphosphonates may have limited ‘protective’ effect against knee OA progression
Women who used bisphosphonates were half as likely as those who did not to experience radiographic progression at 2-year follow up.
Guidelines
New osteoporosis recommendations from AACE help therapy selection
The AACE 2020 updates to diagnosis and treatment guidelines for osteoporosis include recommendations on drug switching and new agent romosozumab...